Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognosis and safety of radium-223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration-resistant prostate cancer: Real-world data of Japanese patients.

Autor: Miyoshi Y; Department of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan., Yasui M; Department of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan., Ttsutsumi S; Department of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan., Kawahara T; Department of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan., Uemura KI; Department of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan., Hayashi N; Department of Urology Graduate School of Medicine Yokohama City University Yokohama Japan., Nozawa M; Department of Urology Faculty Medicine Kindai University Osaka Japan., Yoshimura K; Department of Urology Faculty Medicine Kindai University Osaka Japan., Uemura H; Department of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan., Uemura H; Department of Urology Faculty Medicine Kindai University Osaka Japan.

Publikováno v: BJUI compass [BJUI Compass] 2020 Sep 05; Vol. 2 (1), pp. 31-38. Date of Electronic Publication: 2020 Sep 05 (Print Publication: 2021).